Drug Database
Back to search

France· FR:64005832

ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé

A medicinal product containing éfavirenz + emtricitabine + ténofovir disoproxil (fumarate de), registered in France by GILEAD SCIENCES IRELAND UC (IRLANDE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedATRIPLA 600 mg/200 mg/245 mg, comprim…ATC—REGISTER NO.FR:64005832PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about éfavirenz + emtricitabine + ténofovir disoproxil (fumarate de)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉFAVIRENZ + EMTRICITABINE + TÉNOFOVIR DISOPROXIL (FUMARATE DE)
Manufacturer
GILEAD SCIENCES IRELAND UC (IRLANDE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400938306996
    flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Éfavirenz + emtricitabine + ténofovir disoproxil (fumarate de) in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All éfavirenz + emtricitabine + ténofovir disoproxil (fumarate de) products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
  • Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
  • Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
  • Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
  • Finland · Fatrino
  • United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
  • Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
  • Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
  • Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
  • Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
  • Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
  • Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
  • Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
  • Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd8077eb-6bf4-489e-8410-86221116cc6a
GET /v1/drugs/fd8077eb-6bf4-489e-8410-86221116cc6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64005832",
  "date_amm": "2007-12-13",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/07/430",
  "substance": "ÉFAVIRENZ + EMTRICITABINE + TÉNOFOVIR DISOPROXIL (FUMARATE DE)",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about éfavirenz + emtricitabine + ténofovir disoproxil (fumarate de).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console